<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-ARFRIAA7/c48ba733-dfd4-4f11-9b09-4e84c65d9c23/HTML"><dcterms:extent>27 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-ARFRIAA7/d681235c-6df0-4b6c-b6f0-a5ac7d53b485/PDF"><dcterms:extent>74 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-ARFRIAA7/a0e38b69-1e53-4812-9f90-1ac5fb24c571/TEXT"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-ARFRIAA7"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2010</dcterms:issued><dc:creator>Cvirn Novak, Mateja</dc:creator><dc:creator>Mrhar, Aleš</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:61</dc:format><dc:format xml:lang="sl">str. 117-121</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID:2785905</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-ARFRIAA7</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">debelost</dc:subject><dc:subject xml:lang="sl">farmacevtska skrb</dc:subject><dc:subject xml:lang="sl">telesna masa</dc:subject><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Vloga lekarniškega farmacevta pri obvladovanju čezmerne telesne mase| Community pharmacist's contribution to overweight management|</dc:title><dc:description xml:lang="sl">Overweight and obesity possess one of the greatest public health challenges for the 21st century. Lifestyle change is considered as rational and effectiveway to improve public health. Number of studies confirmed pharmacistćs ability to inform an individual, to improve his motivation for lifestyle changes and to provide long-term monitoring of his results. Models for obesity management from three different countries are presented. As a result an individual weight reduction counseling program in Celje community pharmacy setting was developed, implemented and evaluated. We documented that pharmacy based weight reduction is a valid intervention for obesity management. In addition, we included protocols of Diabetes Care and Pharmaceutical care for hypertension when it was necessary. With such protocols we successfully managed patientćs pharmacotherapy, health status andquality of life. Results from our study are comparable to results of interventions made by other health professionals</dc:description><dc:description xml:lang="sl">Čezmerna telesna masa in debelost predstavljata enega največjih izzivov javnega zdravja v enaindvajsetem stoletju. Za izboljšanje zdravja prebivalstva velja sprememba življenjskega sloga za edini racionalen in učinkovit ukrep. Številne študije so dokazale, da lahko zdravstveni delavci pomembno vplivamo na zmanjšano tveganje za razvoj metaboličnega sindroma. Predstavljeni so trije modeli obvladovanja debelosti iz razlioenih držav ter model za individualno svetovanje in obravnavanje čezmerne telesne mase in debelosti v lekarni, ki smo ga vpeljali v Celjskih lekarnah javnem zavodu. Izvedli smo raziskavo in na osnovi rezultatov ovrednotili prispevek farmacevtske intervencije pri obvladovanju čezmerne telesne mase in debelosti. Uspešnost programa za zmanjševanje telesne mase je primerljiva z uspešnostjo programov, ki jih izvajajo drugi zdravstveni delavci in jim je to delo tudi ovrednoteno in plačano. Program obvladovanja čezmerne telesne mase in debelosti lahko vključuje tudi veljavne protokole za izvajanje farmacevtske skrbi pri sladkorni bolezni in pri hipertenziji</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-ARFRIAA7"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-ARFRIAA7" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-ARFRIAA7/d681235c-6df0-4b6c-b6f0-a5ac7d53b485/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-ARFRIAA7/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-ARFRIAA7" /></ore:Aggregation></rdf:RDF>